<DOC>
	<DOCNO>NCT00212654</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety ONO-1101 postoperative supraventricular tachyarrhythmias .</brief_summary>
	<brief_title>Controlled Study ONO-1101 Patients With Postoperative Tachyarrhythmias Japan</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Landiolol</mesh_term>
	<criteria>1 . 20 year old 2 . Postoperative supraventricular tachyarrhythmias 3 . Within 7 day postoperatively 4 . Other inclusion criterion specify protocol 1 . Acute myocardial infarction ( within 1 month onset ) 2 . Severe heart failure [ New York Heart Association ( NYHA ) functional class III high ] 3 . Atrioventricular block ( grade II high ) , sick sinus syndrome 4 . Other exclusion criterion specify protocol</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>ONO-1101</keyword>
	<keyword>Landiolol Hydrochloride</keyword>
	<keyword>Postoperative</keyword>
	<keyword>supraventricular tachyarrhythmia</keyword>
</DOC>